Prescribers’ perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation. Pharm Pract (Granada) [Internet]. 2020 Jun. 13 [cited 2025 Oct. 3];18(2):1936. Available from: https://pharmacypractice.org/index.php/pp/article/view/1936